David A. Eagle, MD, New York Cancer & Blood Specialists, discusses the present state of treatment for cancer, which often sees patient financial concerns outweighed by the cost of treatment.
David A. Eagle, MD, chair of legislative affairs and patient advocacy at New York Cancer & Blood Specialists, discusses the present state of treatment for cancer, which often sees patient financial concerns outweighed by the cost of treatment. In this interview from our recent Institute for Value-Based Medicine® meeting in New York City on February 8, he addresses potential legislative focus areas to make inroads in this conflict.
Transcript
Can you discuss some of the top legislative priorities that aim to avoid patient financial toxicity but that still consider payer needs and priorities?
I think that’s the heart of the question in modern oncology. We’re in the middle of this tension. We have just enormous advancing scientific progress, but that’s creating enormous financial pressures on the systems. Cancer patients want the best treatment that they can get, and they deserve that. We have an insurance system, unfortunately, that is built around a permanent care model of cost sharing, which just doesn’t work that well with modern oncology. There really aren’t a lot of substitute products, sometimes, for patients.
I think the other important question moving forward, in addition to the finances, is: Who makes the clinical decisions for the patients? I think, as the oncologists, we want to make those decisions for the patients. We know the patients, we kind of know their personal situation, but more and more I think it’s getting harder and harder for us to make sure we have all the clinical authority over what happens to the patients as well.
Initiating BP Medication Linked to Higher Fall, Fracture Risks in Nursing Home Residents
May 2nd 2024Among over 60,000 nursing home residents who initiated antihypertensive medication, rates of excess fractures due to falls per 100 person-years were as high as 5 among certain patient groups, such as those with dementia and high blood pressure (BP).
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More